The article discusses the restructuring plans of San Diego, California-based biotechnology company, Diversa Corp. The company's objective is both to conserve its dwindling cash pile and to focus on building up product sales. Diversa is planning to target alternative energy, specialized industrial processes, and health and nutrition.